NCT02248896View on ClinicalTrials.gov

Antihypertensive Medications and the Risk of Sepsis

CompletedOBSERVATIONAL
Enrollment

1,129,062

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

March 31, 2011

Conditions
Hypertension
Interventions
DRUG

Telmisartan

DRUG

Other angiotensin-receptor blockers (ARBs)

DRUG

Angiotensin-converting enzyme inhibitors (ACEIs)

DRUG

Other major antihypertensive medication classes

e.g. beta-blockers, calcium channel blockers (CCBs), diuretics

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY